Minimal Clinically Important Differences in Measuring Treatment Effects in CIDP: History, Current Use, Limitations,...

Area of Science:

• Neurology
• Clinical Trials
• Outcome Measurement

Background:

• Outcome measures are vital for evaluating treatment efficacy and disease progression in chronic inflammatory demyelinating polyneuropathy (CIDP).
• The concept of minimal clinically important difference (MCID) is increasingly significant in both CIDP research and clinical practice, representing the smallest change perceived as meaningful by patients.
• This review examines the historical application, limitations, and future directions of MCIDs within the context of CIDP.

Purpose of the Study:

• To review the application and derivation of MCIDs in chronic inflammatory demyelinating polyneuropathy (CIDP).
• To evaluate the current utility and limitations of MCIDs for various outcome measures in CIDP.
• To propose future research directions for optimizing MCID use in CIDP.

Main Methods:

• Review of existing literature on MCID derivation and application in CIDP clinical trials and observational studies.
• Analysis of anchor-based and distribution-based methods for MCID calculation.
• Evaluation of MCID thresholds for key CIDP scales including INCAT, ONLS, I-RODS, grip strength, and MRC sum score.

Main Results:

• MCID cut-offs have been established for key CIDP disability scales like INCAT, ONLS, and I-RODS, demonstrating validity and clinical relevance.
• Discrepancies in MCID thresholds exist, particularly for I-RODS and strength measures, with variability influenced by disease severity and subtype.
• MCIDs for strength, walking tests, sensory scales, and electrophysiological measures currently lack sufficient reliability and direct clinical relevance for meaningful benefit assessment in CIDP.

Conclusions:

• MCIDs are valuable for disability measures (INCAT, ONLS, I-RODS) in CIDP research and practice.
• Further research is needed to improve the reliability and clinical relevance of MCIDs for strength and electrophysiological measures in CIDP.
• Future efforts should focus on optimizing outcome measures, harmonizing MCID derivation, and integrating MCIDs with patient-reported quality of life measures in CIDP.